An increasing amount of evidence indicates that NEK2 is significantly upregulated in TNBC [123], potentially driving aggressive tumor behavior and contributing to the high risk of metastasis characteristics and resistance of this cancer subtype [122]. Here, NEK2 is linked to cancer.